Multiple myeloma, version 3.2021

Shaji K. Kumar; Natalie S. Callander; Kehinde Adekola; Larry Anderson; Muhamed Baljevic; Erica Campagnaro; Jorge J. Castillo; Jason C. Chandler; Caitlin Costello; Yvonne Efebera; Matthew Faiman; Alfred Garfall; Kelly Godby; Jens Hillengass; Leona Holmberg; Myo Htut; Carol Ann Huff; Yubin Kang; Malin Hultcrantz; Sarah Larson; Michaela Liedtke; Thomas Martin; James Omel; Kenneth Shain; Douglas Sborov; Keith Stockerl-Goldstein; Donna Weber; Jennifer Keller; Rashmi Kumar

Journal ArticleOPEN ACCESS

Multiple myeloma, version 3.2021

JNCCN Journal of the National Comprehensive Cancer Network (2020) 18(12) 1685-1717

DOI: 10.6004/JNCCN.2020.0057

194Citations

95Readers

Get full text

Abstract

Multiple myeloma is a malignant neoplasm of plasma cells that accumulate in bone marrow, leading to bone destruction and marrow failure. This manuscript discusses the management of patients with solitary plasmacytoma, smoldering multiple myeloma, and newly diagnosed multiple myeloma.

Cite

CITATION STYLE

APA

Kumar, S. K., Callander, N. S., Adekola, K., Anderson, L., Baljevic, M., Campagnaro, E., … Kumar, R. (2020). Multiple myeloma, version 3.2021. JNCCN Journal of the National Comprehensive Cancer Network, 18(12), 1685–1717. https://doi.org/10.6004/JNCCN.2020.0057

Multiple myeloma, version 3.2021

Abstract

Cite

Register to see more suggestions